James Investment Research’s Natus Medical Inc NTUS Stock Holding History

James Investment Research’s Portfolio NTUS Stock Details NTUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-116,230	Closed	-$5.58M	–	492
2015 Q4	$5.58M	Buy	116,230 +64,385	+124%	+$2.98M	0.14%	138
2015 Q3	$2.04M	Buy	51,845 +2,075	+4%	+$88.2K	0.05%	174
2015 Q2	$2.12M	Hold	49,770	–	–	0.05%	191
2015 Q1	$1.96M	Sell	49,770 -20,300	-29%	-$749K	0.05%	200
2014 Q4	$2.52M	Buy	70,070 +3,830	+6%	+$129K	0.07%	173
2014 Q3	$1.96M	Buy	66,240 +10,910	+20%	+$301K	0.06%	178
2014 Q2	$1.39M	Hold	55,330	–	–	0.04%	197
2014 Q1	$1.43M	Buy	+55,330	New	+$1.39M	0.05%	205

Other funds holding NTUS

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

James Investment Research's NTUS Position: Q1 2016 in Review

James Investment Research sold out of Natus Medical Inc (NTUS) in Q1 2016, closing a stake of 116,230 shares — an estimated $5.58M sold.

James Investment Research first reported a position in NTUS in Q1 2014 and held it in 8 quarters. The position peaked at $5.58M in Q4 2015. 207 funds tracked by Wall St. Rank hold NTUS as of Q1 2016.

James Investment Research reported no remaining Natus Medical Inc position as of Q1 2016 after selling out during the quarter.
James Investment Research sold 116,230 Natus Medical Inc shares in Q1 2016, an estimated $5.58M.
James Investment Research first reported a position in Natus Medical Inc in Q1 2014 and held it in 8 quarters.
James Investment Research's Natus Medical Inc position peaked at $5.58M in Q4 2015.
207 funds tracked by Wall St. Rank held Natus Medical Inc as of Q1 2016.

Based on James Investment Research's 13F filing for Q1 2016, filed 25 Apr 2016.